advertisements
26.02.2024
Expert*in Governance für Recruitingprozesse inkl. Vendormanagement (m/w/d)
Germany, Frankfurt Taunusanlage 12
... regionalen Projekten mit. Ihre Erfahrungen und Fähigkeiten Sie verfügen über ein abgeschlossenes Hochschulstudium oder vergleichbare Qualifikationen sowie über fundierte einschlägige Berufserfahrung im Personalbereich, idealerweise im Recruiting oder in vergleichbaren Bereichen/Tätigkeiten. Sie ...
More »
0010 Deutsche Bank Aktiengesellschaft
23.02.2024
Mission Assurance Engineer
United States of America, UTCLB14
... Engineer. The Mission Assurance team monitors mission assurance program specifications and processes to ensure the mission success of the program and works with the various teams to promote continuous MRB reduction and process improvements are implemented. In addition, we assess program ...
More »
0899 AS - Aerospace Structures
14.07.2024
ERP Engineer
United Kingdom, Manor Royal Crawley
... Engineer Location Crawley/Belfast/Glasgow/Templecombe (Any Thales Site in the UK) Closing Date for Application: Thursday 2nd Oct’23 Our Opportunity The role will require experience and capability in standard lifecycle activities - requirements mapping, gap analysis, conference room pilots, UAT ...
More »
Thales UK Limited
04.08.2024
CB- Financial Institution Coverage Banker- VP
Hong Kong, Hong Kong, Intl Commerce Ctr
... Regional Relationship Management and product teams that Deutsche Bank is the provider of choice for clients and that all avenues for working with our client across different geographies and products are explored. Involve senior management in key client presentations to emphasize alignment with ...
More »
0786 Deutsche Bank Aktiengesellschaft, Filiale Hongkong
09.07.2023
chef de projet et coordonnateur du contenu graphique aux Affaires réglementaires / Regulatory Affairs Project Leader, Artwork Coordinator
Canada, Montreal Queen Street
... avons obtenu 13 approbations importantes. Nous avons plus que doublé le nombre de nouveaux vaccins et de médicaments en cours d’études cliniques de phase III, qui s’élèvent maintenant à 23 au total. Nos produits en développement, soit 21 vaccins et 43 médicaments, pourraient s’avérer être les ...
More »
837 GlaxoSmithKline Inc.